- Exchange: EN Brussels
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Ablynx NV+ Add to Watchlist
ABLX:BB8.4020 EUR 0.1220 1.47%
As of 11:35:00 ET on 09/19/2014.
Company Profile for Ablynx NV (ABLX)
Ablynx NV is a biopharmaceutical company. The Company discovers and develops therapeutic protein treatments for human diseases.
Key Executives for Ablynx NV (ABLX)
|Edwin MosesChief Executive Officer||Wim OttevaereChief Financial Officer|
|Josefin-Beate Holz "Josi"Chief Medical Officer||Marieke VermeerschAssociate Dir:Investor Relations|